ID   RzM6-LC
AC   CVCL_D637
DR   BTO; BTO:0005181
DR   cancercelllines; CVCL_D637
DR   Wikidata; Q54951522
RX   PubMed=19861417;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D636 ! RzM6
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
RX   PubMed=19861417; DOI=10.1074/jbc.M109.043232;
RA   Nishimura T., Kohara M., Izumi K., Kasama Y., Hirata Y., Huang Y.,
RA   Shuda M., Mukaidani C., Takano T., Tokunaga Y., Nuriya H., Satoh M.,
RA   Saito M., Kai C., Tsukiyama-Kohara K.;
RT   "Hepatitis C virus impairs p53 via persistent overexpression of
RT   3beta-hydroxysterol Delta24-reductase.";
RL   J. Biol. Chem. 284:36442-36452(2009).
//